ClinicalTrials.Veeva

Menu

Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer (PanC-YOUNG)

I

Integrated University Hospital Trust of Verona

Status

Enrolling

Conditions

PDAC - Pancreatic Ductal Adenocarcinoma

Treatments

Other: Register

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.

Enrollment

3,000 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≤55 years old at the time of diagnosis of pancreatic cancer
  • Age ≥ 18 years
  • Written informed consent obtained.

Exclusion criteria

  • Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
  • Absence of informed consent.
  • Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer

Trial contacts and locations

1

Loading...

Central trial contact

Fabio Casciani

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems